Publicaciones en las que colabora con CRISTINA MARCOS ARIAS (27)

2022

  1. In vitro and in vivo anti-Candida activity of citral in combination with fluconazole

    Journal of Oral Microbiology, Vol. 14, Núm. 1

  2. In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study

    Frontiers in Cellular and Infection Microbiology, Vol. 12

2021

  1. Development and characterization of monoolein-based liposomes of carvacrol, cinnamaldehyde, citral, or thymol with anti-candida activities

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 4

  2. Erratum: Development and characterization of monoolein-based liposomes of carvacrol, cinnamaldehyde, citral, or thymol with Anti-Candida activities (Antimicrobial Agents and Chemotherapy (2021) 65:4 (e01628-20) DOI: 10.1128/AAC.01628-20)

    Antimicrobial Agents and Chemotherapy

  3. In vitro activities of carvacrol, cinnamaldehyde and thymol against Candida biofilms

    Biomedicine and Pharmacotherapy, Vol. 143

2020

  1. Candida duobushaemulonii: An old but unreported pathogen

    Journal of Fungi, Vol. 6, Núm. 4, pp. 1-11

  2. Utility of two PCR-RFLP-based techniques for identification of Candida parapsilosis complex blood isolates

    Mycoses, Vol. 63, Núm. 5, pp. 461-470

2019

  1. Corrigendum: Antifungal activity of the human uterine cervical stem cells conditioned medium (hUCESC-CM) against candida albicans and other medically relevant species of candida (Frontiers in Microbiology (2018) 9 (2818) DOI: 10.3389/fmicb.2018.02818)

    Frontiers in Microbiology

  2. Therapeutic tools for oral candidiasis: Current and new antifungal drugs

    Medicina oral, patologia oral y cirugia bucal, Vol. 24, Núm. 2, pp. e172-e180

  3. Therapeutic tools for oral candidiasis: current and new antifungal drugs

    Medicina oral, patología oral y cirugía bucal. Ed. inglesa, Vol. 24, Núm. 2, pp. 10

2018

  1. Antifungal activity of the human uterine cervical stem cells conditioned medium (hUCESC-CM) against candida albicansand other medically relevant species of candida

    Frontiers in Microbiology, Vol. 9, Núm. NOV

  2. Oral Candida colonization in patients with chronic periodontitis. Is there any relationship?

    Revista Iberoamericana de Micologia, Vol. 35, Núm. 3, pp. 134-139

  3. Prevalence and antifungal susceptibility profiles of Candida glabrata, Candida parapsilosis and their close-related species in oral candidiasis

    Archives of Oral Biology, Vol. 95, pp. 100-107

  4. The continuous changes in the aetiology and epidemiology of invasive candidiasis: from familiar Candida albicans to multiresistant Candida auris

    International microbiology: official journal of the Spanish Society for Microbiology, Vol. 21, Núm. 3, pp. 107-119

2017

  1. In Vitro Antifungal Susceptibility of Oral Candida Isolates from Patients Suffering from Caries and Chronic Periodontitis

    Mycopathologia, Vol. 182, Núm. 5-6, pp. 471-485

  2. Usefulness of the Non-conventional Caenorhabditis elegans Model to Assess Candida Virulence

    Mycopathologia, Vol. 182, Núm. 9-10, pp. 785-795

2016

  1. Caries and Candida colonisation in adult patients in Basque Country (Spain)

    Mycoses, Vol. 59, Núm. 4, pp. 234-240

2015

  1. "Galleria mellonella" como modelo alternativo para evaluar la virulencia de especies de "Candida"

    Avances en microbiología

2013

  1. Presence of Candida in recurrent aphthous stomatitis

    Revista Iberoamericana de Micologia

  2. Sertaconazole: An antifungal agent for the topical treatment of superficial candidiasis

    Expert Review of Anti-Infective Therapy, Vol. 11, Núm. 4, pp. 347-358